ro 31-8220 has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
Ro 31-8220: a protein kinase C inhibitor
| Excerpt | Relevance | Reference |
|---|---|---|
| "These data indicate that the formation of O2- by the endothelial gp91phox-containing NADPH oxidase accounts for the reduced NO bioavailability in the 2K1C model and contributes to the development of renovascular hypertension and endothelial dysfunction." | 1.32 | gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. ( Brandes, RP; Busse, R; Geiger, H; Jung, O; Pedrazzini, T; Schreiber, JG, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, O | 1 |
| Schreiber, JG | 1 |
| Geiger, H | 1 |
| Pedrazzini, T | 1 |
| Busse, R | 1 |
| Brandes, RP | 1 |
1 other study available for ro 31-8220 and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcholine; Angiotensin II; Animals; Anti | 2004 |